Chance meeting five years ago leads to biotech startup CEO landing a Biogen biggie for her board
Verge Genomics, which is coupling human brain disease data with artificial intelligence and machine learning, looks to take its first drug into a clinical trial this year against amyotrophic lateral sclerosis.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ron Leuty Source Type: news
More News: ALS | Biotechnology | Brain | Clinical Trials | Health Management | Learning | Neurology | Universities & Medical Training